Kiadis Pharma NV (Kiadis Pharma NV) ROE % Adjusted to Book Value : 0.00% (As of Dec. 2020)

View and export this data going back to 2016. Start your Free Trial

What is Kiadis Pharma NV ROE % Adjusted to Book Value?

Kiadis Pharma NV's ROE % for the quarter that ended in Dec. 2020 was 0.00%. Kiadis Pharma NV's PB Ratio for the quarter that ended in Dec. 2020 was N/A. Kiadis Pharma NV's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2020 was N/A.

Kiadis Pharma NV ROE % Adjusted to Book Value Historical Data

The historical data trend for Kiadis Pharma NV's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kiadis Pharma NV ROE % Adjusted to Book Value Chart

Kiadis Pharma NV Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-11.64

-21.60

-74.02

Kiadis Pharma NV Semi-Annual Data
	Dec12	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20
ROE % Adjusted to Book Value	Get a 7-Day Free Trial											-19.71	-26.01	-62.83	-55.31	-

Competitive Comparison of Kiadis Pharma NV's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Kiadis Pharma NV's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kiadis Pharma NV's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Kiadis Pharma NV's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Kiadis Pharma NV's ROE % Adjusted to Book Value falls into.

Kiadis Pharma NV ROE % Adjusted to Book Value Calculation

Kiadis Pharma NV's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2020 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	0.00%	/	N/A
	=	N/A

Kiadis Pharma NV's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2020 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	0.00%	/	N/A
	=	N/A

Kiadis Pharma NV ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Kiadis Pharma NV's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Kiadis Pharma NV (Kiadis Pharma NV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kiadis Pharma NV (GREY:KIADF) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

Paasheuvelweg 25A, Amsterdam, NLD, 1105 BP

Website

https://www.kiadis.com

Kiadis Pharma NV is a Netherlands based clinical-stage biopharmaceutical company. It is focused on research, development, and commercialization of cell-based immunotherapy products for the treatment of blood cancers and inherited blood disorders. The company's product pipeline includes K-NK002, K-NK003, K-NK00X, and others.

Kiadis Pharma NV (Kiadis Pharma NV) Headlines

No Headlines